Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02267577 · ClinicalTrials.gov registry record · NA

Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers

A NA study, sponsored by William Marsh Rice University.

Completed
Registry status
NA
Development phase
90
Enrollment target

NCT02267577 is a NA study that has completed, run by William Marsh Rice University. The registered enrollment target is 90 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02267577, a NA study, has completed, sponsored by William Marsh Rice University.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target

Study Summary

The research team has developed an automatic blood pressure monitor (Sphygmo) to be used for the monitoring and diagnosis of pre-eclampsia in pregnant women, particularly in low-resource settings where current monitoring is limited. 90 adult volunteers will be enrolled by researchers at Rice University. The participant will be seated in a comfortable chair with arm at heart level. Arm circumference will be measured and a blood pressure cuff will be placed on the arm. The cuff will be inflated and blood pressure measurements will be taken by a commercially available device and by the Sphygmo device. Blood pressure measurements from both devices will be recorded. The participant's blood pressure will be measured up to 9 times with a waiting period of 45-60 seconds between each measurement. The results of this study will be used to optimize the blood pressure detection algorithm and thus further develop the device.

Interventions

  • DEVICE Sphygmo: Automatic Blood Pressure Monitor
  • DEVICE GE Dinamap ProCare Automatic Blood Pressure Monitor

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2015-01
Est. Completion 2017-10-12
Phase NA

Sponsor

William Marsh Rice University

8 total trials

What the Registry Record Tells You About NCT02267577

The ClinicalTrials.gov registry entry for NCT02267577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is William Marsh Rice University, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sphygmo: Automatic Blood Pressure Monitor is the first listed.

NCT02267577 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02267577 about?

NCT02267577 is a clinical study titled "Accuracy Assessment of an Automatic Blood Pressure Measurement Device in Adult Volunteers". The research team has developed an automatic blood pressure monitor (Sphygmo) to be used for the monitoring and diagnosis of pre-eclampsia in pregnant women, particularly in low-resource settings where current monitoring is limited. 90 adult volunteers will be enrolled by researchers at Rice Univer...

What is the current status of trial NCT02267577?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-01. Estimated completion is 2017-10-12.

What interventions are being tested in trial NCT02267577?

The interventions under investigation include: Sphygmo: Automatic Blood Pressure Monitor (DEVICE), GE Dinamap ProCare Automatic Blood Pressure Monitor (DEVICE).

Who is sponsoring clinical trial NCT02267577?

This trial is sponsored by William Marsh Rice University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.